EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Semiconducting Polymers for Cancer Immunotherapy

Wen Li, Mengyun Liang, Ji Qi, Dan Ding iD

Macromolecular Rapid Communications · 2023

DOI: 10.1002/marc.202300496 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Macromolecular Rapid Communications, 2023. Verfasst von Wen Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Biomedical Materials and Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedica…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: National Natural Science Youth Science Foundation Project, NSFC, CAMS Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a monumental breakthrough in cancer treatment, immunotherapy has attracted tremendous attention in recent years. However, one challenge faced by immunotherapy is the low response rate and the immune‐related adverse events (irAEs). Therefore, it is important to explore new therapeutic strategies and platforms for boosting therapeutic benefits and decreasing the side effects of immunotherapy. In recent years, semiconducting polymer (SP), a category of organic materials with π‐conjugated aromatic backbone, has been attracting considerable attention because of their outstanding characteristics such as excellent photophysical features, good biosafety, adjustable chemical flexibility, easy fabrication, and high stability. With these distinct advantages, SP is extensively explored for bioimaging and photo‐ or ultrasound‐activated tumor therapy. Here, the recent advancements in SP‐based nanomedicines are summarized for enhanced tumor immunotherapy. According to the photophysical properties of SPs, the cancer immunotherapies enabled by SPs with the photothermal, photodynamic, or sonodynamic functions are highlighted in detail, with a particular focus on the construction of combination immunotherapy and activatable nanoplatforms to maximize the benefits of cancer immunotherapy. Herein, new guidance and comprehensive insights are provided for the design of SPs with desired photophysical properties to realize maximized effectiveness of required biomedical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsHumansPhototherapyPolymersImmunotherapy

Stichwörter der Autor:innen

cancersimmunogenic cell deathimmunotherapyphototherapysemiconducting polymers

Substanzen

Polymers

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Biomedical Materials and Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Me…
  • State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, and College of Life Sciences, Nankai University, Tianjin, 300071, China.
  • School of Materials Science and Engineering & Smart Sensing Interdisciplinary Science Center, Nankai University, Tianjin, 300350, China.

ORCID-Profile: Dan Ding

Förderung

  • National Natural Science Youth Science Foundation Project
  • NSFC
  • CAMS Initiative for Innovative Medicine
  • Science and Technology Program of Tianjin
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Li, W., Liang, M., Qi, J., & Ding, D. (2023). Semiconducting Polymers for Cancer Immunotherapy. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202300496

Vancouver

Li W, Liang M, Qi J, Ding D. Semiconducting Polymers for Cancer Immunotherapy. Macromolecular Rapid Communications. 2023. doi:10.1002/marc.202300496

BibTeX
@article{Li2023,
  author = {Li, Wen and Liang, Mengyun and Qi, Ji and Ding, Dan},
  title = {Semiconducting Polymers for Cancer Immunotherapy},
  journal = {Macromolecular Rapid Communications},
  year = {2023},
  doi = {10.1002/marc.202300496}
}
Kostenlos starten →